AAAAAA
Results:
1-21
|
Results: 21
Authors:
Haq, IU
Ramsay, LE
Wallis, EJ
Isles, CG
Ritchie, LD
Jackson, PR
Citation: Iu. Haq et al., Population implications of lipid lowering for prevention of coronary heartdisease: data from the 1995 Scottish Health Survey, HEART, 86(3), 2001, pp. 289-295
Authors:
Sanmuganathan, PS
Ghahramani, P
Jackson, PR
Wallis, EJ
Ramsay, LE
Citation: Ps. Sanmuganathan et al., Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials, HEART, 85(3), 2001, pp. 265-271
Authors:
Jackson, PR
Wallis, EJ
Haq, IU
Ramsay, LE
Citation: Pr. Jackson et al., Statins for primary prevention: at what coronary risk is safety assured?, BR J CL PH, 52(4), 2001, pp. 439-446
Authors:
Wallis, EJ
Ramsay, LE
Haq, IU
Ghahramani, P
Jackson, PR
Citation: Ej. Wallis et al., Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation, J HYPERTENS, 19(4), 2001, pp. 691-696
Authors:
Jackson, PR
Wallis, EJ
Ramsay, LE
Citation: Pr. Jackson et al., Prevention of stroke and transient ischaemic attack, LANCET, 358(9283), 2001, pp. 762-762
Authors:
Ramsey, LE
Sanmuganathan, PS
Wallis, EJ
Jackson, PR
Citation: Le. Ramsey et al., Aspirin for primary prevention - Treatment policy should be based on all trial evidence, not subgroup analysis, BR MED J, 321(7274), 2000, pp. 1472-1472
Optimal age for starting lipid lowering treatment - Adjusted data do not justify a lower optimal age
Authors:
Jackson, PR
Wallis, EJ
Ramsay, LE
Citation: Pr. Jackson et al., Optimal age for starting lipid lowering treatment - Adjusted data do not justify a lower optimal age, BR MED J, 321(7261), 2000, pp. 637-638
Authors:
Wallis, EJ
Ramsay, LE
Yikona, JINM
Jackson, PR
Citation: Ej. Wallis et al., Comparison of methods of estimating coronary risk - Authors did not use latest version of Sheffield table, BR MED J, 321(7254), 2000, pp. 175-176
Authors:
Wallis, EJ
Citation: Ej. Wallis, Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population(vol 320, pg 671, 2000), BR MED J, 320(7241), 2000, pp. 1034-1034
Authors:
Wallis, EJ
Ramsay, LE
Haq, IU
Ghahramani, P
Jackson, PR
Rowland-Yeo, K
Yeo, WW
Citation: Ej. Wallis et al., Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population, BR MED J, 320(7236), 2000, pp. 671-676
Authors:
Ramsay, LE
Wallis, EJ
Yeo, WW
Jackson, PR
Citation: Le. Ramsay et al., Absolute and relative risk in hypertension, HBK HYPERT, 20, 2000, pp. 43-56
Authors:
Haq, IU
Ramsay, LE
Jackson, PR
Wallis, EJ
Citation: Iu. Haq et al., Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods, QJM-MON J A, 92(7), 1999, pp. 379-385
Authors:
Haq, IU
Ramsay, LE
Yeo, WW
Jackson, PR
Wallis, EJ
Citation: Iu. Haq et al., Is the Framingham risk function valid for northern European populations? Acomparison of methods for estimating absolute coronary risk in high risk men, HEART, 81(1), 1999, pp. 40-46
Authors:
Ramsay, LE
Wallis, EJ
Haq, IU
Jackson, PR
Yeo, WW
Citation: Le. Ramsay et al., Policy based on Sheffield table fully satisfies authors' criteria, BR MED J, 318(7191), 1999, pp. 1140-1141
Authors:
Yeo, KR
Yeo, WW
Wallis, EJ
Ramsay, LE
Citation: Kr. Yeo et al., Enhanced cholesterol reduction by simvastatin in diltiazem-treated patients, BR J CL PH, 48(4), 1999, pp. 610-615
Authors:
Nicholson, K
Ramsay, LE
Haq, IU
Wallis, EJ
Ghahramani, P
Jackson, PR
Yeo, WW
Citation: K. Nicholson et al., Factors affecting the acceptance of drug therapy to prevent myocardial infarction, BR J CL PH, 47(5), 1999, pp. 580-580
Authors:
Haq, IU
Minnis, R
Wallis, EJ
Palmer, R
Yeo, WW
Jackson, PR
Ramsay, LE
Citation: Iu. Haq et al., Randomized trial of step-3 diet vs simvastatin therapy for reduction in risk of coronary heart disease, BR J CL PH, 47(5), 1999, pp. 597-598
Authors:
Wallis, EJ
Yeo, WW
Jackson, PR
Ramsay, LE
Citation: Ej. Wallis et al., Effect on ACE inhibitor cough of replacing the ACE inhibitor with losartan, BR J CL PH, 47(5), 1999, pp. 598-599
Authors:
Ul Haq, I
Wallis, EJ
Jackson, PR
Yeo, WW
Ramsay, LE
Citation: I. Ul Haq et al., Implication of recent trials with b-hydroxy-b-methylglutaryl coenzyme A reductase inhibitors for hypertension management, J HYPERTENS, 17(11), 1999, pp. 1641-1646
Authors:
Ramsay, LE
Wallis, EJ
Haq, IU
Jackson, PR
Citation: Le. Ramsay et al., Coronary risk assessment methods and cholesterol lowering, LANCET, 353(9158), 1999, pp. 1095-1095
Authors:
Haq, IU
Wallis, EJ
Yee, WW
Jackson, PR
Ramsay, LE
Citation: Iu. Haq et al., Coronary events with lipid-lowering therapy: The AFCAPS/TexCAPS trial, J AM MED A, 281(5), 1999, pp. 414-414
Risultati:
1-21
|